BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37293090)

  • 1. Subtype-specific circadian clock dysregulation modulates breast cancer biology, invasiveness, and prognosis.
    Hammarlund JA; Li SY; Wu G; Lian JW; Howell SJ; Clarke R; Adamson A; Gonçalves CF; Hogenesch JB; Meng QJ; Anafi RC
    bioRxiv; 2023 May; ():. PubMed ID: 37293090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer.
    Li SY; Hammarlund JA; Wu G; Lian JW; Howell SJ; Clarke RB; Adamson AD; Gonçalves CF; Hogenesch JB; Anafi RC; Meng QJ
    Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2311854121. PubMed ID: 38319971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks.
    De A; Beligala DH; Sharma VP; Burgos CA; Lee AM; Geusz ME
    Clin Exp Metastasis; 2020 Oct; 37(5):617-635. PubMed ID: 32816185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krüppel-like factor 9 (KLF9) links hormone dysregulation and circadian disruption to breast cancer pathogenesis.
    Ybañez WS; Bagamasbad PD
    Cancer Cell Int; 2023 Feb; 23(1):33. PubMed ID: 36823570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
    Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
    Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circadian clock is disrupted in pancreatic cancer.
    Schwartz PB; Nukaya M; Berres ME; Rubinstein CD; Wu G; Hogenesch JB; Bradfield CA; Ronnekleiv-Kelly SM
    PLoS Genet; 2023 Jun; 19(6):e1010770. PubMed ID: 37262074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for widespread dysregulation of circadian clock progression in human cancer.
    Shilts J; Chen G; Hughey JJ
    PeerJ; 2018; 6():e4327. PubMed ID: 29404219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin: an inhibitor of breast cancer.
    Hill SM; Belancio VP; Dauchy RT; Xiang S; Brimer S; Mao L; Hauch A; Lundberg PW; Summers W; Yuan L; Frasch T; Blask DE
    Endocr Relat Cancer; 2015 Jun; 22(3):R183-204. PubMed ID: 25876649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes.
    Rossetti S; Esposito J; Corlazzoli F; Gregorski A; Sacchi N
    Cell Cycle; 2012 Jan; 11(2):350-60. PubMed ID: 22193044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian clocks and breast cancer.
    Blakeman V; Williams JL; Meng QJ; Streuli CH
    Breast Cancer Res; 2016 Sep; 18(1):89. PubMed ID: 27590298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sleep-wake distribution contributes to the peripheral rhythms in PERIOD-2.
    Hoekstra MM; Jan M; Katsioudi G; Emmenegger Y; Franken P
    Elife; 2021 Dec; 10():. PubMed ID: 34895464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupting circadian rhythms promotes cancer-induced inflammation in mice.
    Lawther AJ; Phillips AJK; Chung NC; Chang A; Ziegler AI; Debs S; Sloan EK; Walker AK
    Brain Behav Immun Health; 2022 May; 21():100428. PubMed ID: 35199050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of circadian-related gene expression profiles in entrained breast cancer cell lines.
    Gutiérrez-Monreal MA; Treviño V; Moreno-Cuevas JE; Scott SP
    Chronobiol Int; 2016; 33(4):392-405. PubMed ID: 27010605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cancer Clock Is (Not) Ticking: Links between Circadian Rhythms and Cancer.
    Morgan MN; Dvuchbabny S; Martinez CA; Kerr B; Cistulli PA; Cook KM
    Clocks Sleep; 2019 Dec; 1(4):435-458. PubMed ID: 33089179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
    Han Y; Meng F; Venter J; Wu N; Wan Y; Standeford H; Francis H; Meininger C; Greene J; Trzeciakowski JP; Ehrlich L; Glaser S; Alpini G
    J Hepatol; 2016 Jun; 64(6):1295-304. PubMed ID: 26923637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real time, in vivo measurement of neuronal and peripheral clocks in
    Johnstone PS; Ogueta M; Akay O; Top I; Syed S; Stanewsky R; Top D
    Elife; 2022 Oct; 11():. PubMed ID: 36190119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of circadian clock genes in human colorectal adenoma and carcinoma.
    Momma T; Okayama H; Saitou M; Sugeno H; Yoshimoto N; Takebayashi Y; Ohki S; Takenoshita S
    Oncol Lett; 2017 Nov; 14(5):5319-5325. PubMed ID: 29113166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-tissue transcriptional changes and core circadian clock disruption following intensive care.
    Hollis HC; Francis JN; Anafi RC
    Front Physiol; 2022; 13():942704. PubMed ID: 36045754
    [No Abstract]   [Full Text] [Related]  

  • 19. Dysregulation, functional implications, and prognostic ability of the circadian clock across cancers.
    Liu Z; Yu K; Zheng J; Lin H; Zhao Q; Zhang X; Feng W; Wang L; Xu J; Xie D; Zuo ZX; Liu ZX; Zheng Q
    Cancer Med; 2019 Apr; 8(4):1710-1720. PubMed ID: 30791227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clock proteins regulate spatiotemporal organization of clock genes to control circadian rhythms.
    Xiao Y; Yuan Y; Jimenez M; Soni N; Yadlapalli S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34234015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.